How much funding has Breathonix raised?

Breathonix has raised $5.0M in total funding, most recently a Series A round.

Who are Breathonix's investors?

Breathonix's investors include Antler, MedTech Innovator, SLINGSHOT (Singapore).

When was Breathonix founded?

Breathonix was founded in 2020.

Where is Breathonix headquartered?

Breathonix is headquartered in Singapore, Singapore.

What industry is Breathonix in?

Breathonix operates in Healthcare.

How many employees does Breathonix have?

Breathonix has 11-50 employees.

Breathonix

Diagnostics Reimagined

Singapore, Singapore · Founded 2020 · $5.0M raised

Healthcare

Headquarters: Singapore
Employees: 11–50
Founded: 2020
Business Model: B2B

Website: breathonix.com
Total Funding: $5.0M
Last Round: $5.0M Series AMay 2021
Rounds: 2

About

Breathonix is a Singapore-based deep-tech company founded by NUS researchers that pioneers non-invasive breath analysis for disease screening. The company was the first globally to receive regulatory approval for a VOC-based breath test, developing portable devices that leverage mass spectrometry and AI-driven biomarker detection. Its flagship products include BreFence Go for rapid COVID-19 detection and MetaDR™, an FDA-registered handheld breath analyzer for ketone monitoring used in diabetes and epilepsy management.

Summary

Breathonix is a Healthcare company based in Singapore, Singapore, founded in 2020. It has raised $5.0M in total across 2 rounds, most recently a $5.0M Series A round in May 2021. Investors include Antler, MedTech Innovator and SLINGSHOT (Singapore).